← Open Payments lookup

DOREEN FUKUSHIMA: Open Payments

NPI 1205030111 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,977 in 129 payments from 12 companies in 2025. Trend: 2023 $4,204 · 2024 $3,958 · 2025 $3,977

Food & beverage: $3,977
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$647
ABBVIE INC.20$622
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$515
Vanda Pharmaceuticals Inc.11$378
Neurocrine BioSciences, Inc.4$365
Axsome Therapeutics, Inc.10$346
Alkermes, Inc.21$333
Lundbeck LLC11$279
E.R. Squibb & Sons, L.L.C.5$229
Neuronetics, Inc.2$111

Products named: REXULTI, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, FANAPT, INGREZZA, Auvelity, ARISTADA.

Industry payments across CA — which companies pay providers there.